Sign in to edit your profile (add interests, overview, photo, etc.)

    Baker, Suzanne

    TitleResearch Assoc Staff
    SchoolLawrence Berkeley National Lab
    DepartmentMolecular Biophys & Integ Bio
    Address1 Cyclotron Road
    Berkeley CA 94720
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker S, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, Rosen HJ, Tsai R, Visani AV, Miller BL, Jagust WJ, Rabinovici GD. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. 2017 Dec 27. PMID: 29282337.
        View in: PubMed
      2. Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker S, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, ß-Amyloid, and Cognition in Parkinson Disease. JAMA Neurol. 2017 Dec 11. PMID: 29228071.
        View in: PubMed
      3. Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker S, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain. 2017 Dec 01; 140(12):3286-3300. PMID: 29053874.
        View in: PubMed
      4. Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker S, Rabinovici GD, Jagust WJ. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging. J Neurosci. 2018 Jan 17; 38(3):530-543. PMID: 29192126.
        View in: PubMed
      5. Baker S, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017 Dec; 15:648-657. PMID: 29124088.
        View in: PubMed
      6. Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker S, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Ann Neurol. 2017 Oct; 82(4):622-634. PMID: 28980714.
        View in: PubMed
      7. Iaccarino L, Tammewar G, Ayakta N, Baker S, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage Clin. 2018; 17:452-464. PMID: 29159058.
        View in: PubMed
      8. Berry AS, Shah VD, Furman DJ, White RL, Baker S, O'Neil JP, Janabi M, D'Esposito M, Jagust WJ. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but not Dopamine Release. Neuropsychopharmacology. 2017 Aug 17. PMID: 28816243.
        View in: PubMed
      9. Maass A, Landau S, Baker S, Horng A, Lockhart SN, La Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease. Neuroimage. 2017 Aug 15; 157:448-463. PMID: 28587897.
        View in: PubMed
      10. Lockhart SN, Schöll M, Baker S, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage. 2017 Apr 15; 150:191-199. PMID: 28232190.
        View in: PubMed
      11. Marks SM, Lockhart SN, Baker S, Jagust WJ. Tau and ß-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging. J Neurosci. 2017 Mar 22; 37(12):3192-3201. PMID: 28213439.
        View in: PubMed
      12. Berry AS, Shah VD, Baker S, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ. Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility. J Neurosci. 2016 Dec 14; 36(50):12559-12569. PMID: 27807030.
        View in: PubMed
      13. Baker S, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. J Nucl Med. 2017 Feb; 58(2):332-338. PMID: 27587706.
        View in: PubMed
      14. Lockhart SN, Baker S, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. PLoS One. 2016; 11(6):e0158460. PMID: 27355840; PMCID: PMC4927104.
      15. Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker S, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain. 2016 May; 139(Pt 5):1551-67. PMID: 26962052; PMCID: PMC5006248 [Available on 05/01/17].
      16. Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker S, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016 Mar 2; 89(5):971-82. PMID: 26938442.
        View in: PubMed
      17. Shokouhi S, Mckay JW, Baker S, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP. Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment. Alzheimers Res Ther. 2016 Jan 15; 8:2. PMID: 26768154; PMCID: PMC4714472.
      18. Boutchko R, Mitra D, Baker S, Jagust WJ, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. J Cereb Blood Flow Metab. 2015 Jul; 35(7):1104-11. PMID: 25899294; PMCID: PMC4640278.
      19. Landau SM, Fero A, Baker S, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal ß-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015 Apr; 56(4):567-74. PMID: 25745095.
        View in: PubMed
      20. Ossenkoppele R, Schonhaut DR, Baker S, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Ann Neurol. 2015 Feb; 77(2):338-42. PMID: 25448043; PMCID: PMC4382124.
      21. Elman JA, Madison CM, Baker S, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cereb Cortex. 2016 Feb; 26(2):695-707. PMID: 25405944; PMCID: PMC4712800 [Available on 02/01/17].
      22. Elman JA, Oh H, Madison CM, Baker S, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Neural compensation in older people with brain amyloid-ß deposition. Nat Neurosci. 2014 Oct; 17(10):1316-8. PMID: 25217827; PMCID: PMC4177011.
      23. Bailey MJ, van der Weegen R, Klemm PJ, Baker S, Helms BA. Stealth rare earth oxide nanodiscs for magnetic resonance imaging. Adv Healthc Mater. 2012 Jul; 1(4):437-42. PMID: 23184774.
        View in: PubMed
      24. Mittermeyer G, Christine CW, Rosenbluth KH, Baker S, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther. 2012 Apr; 23(4):377-81. PMID: 22424171; PMCID: PMC4530392.
      25. Mormino EC, Brandel MG, Madison CM, Marks S, Baker S, Jagust WJ. Aß Deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex. 2012 Aug; 22(8):1813-23. PMID: 21945849; PMCID: PMC3388896.
      26. Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker S, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 2012 Jan 16; 59(2):1152-60. PMID: 21884802; PMCID: PMC3230690.
      27. Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker S, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between ß-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex. 2011 Oct; 21(10):2399-407. PMID: 21383234; PMCID: PMC3169663.
      28. Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker S, Madison CM, Jagust WJ. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum Brain Mapp. 2011 Jun; 32(6):947-61. PMID: 20578173; PMCID: PMC3176660.
      29. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker S, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain. 2010 Feb; 133(Pt 2):512-28. PMID: 20080878; PMCID: PMC2858015.
      30. Que EL, Gianolio E, Baker S, Aime S, Chang CJ. A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility. Dalton Trans. 2010 Jan 14; (2):469-76. PMID: 20023983.
        View in: PubMed
      31. Que EL, Gianolio E, Baker S, Wong AP, Aime S, Chang CJ. Copper-responsive magnetic resonance imaging contrast agents. J Am Chem Soc. 2009 Jun 24; 131(24):8527-36. PMID: 19489557.
        View in: PubMed
      32. Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker S, Madison CM, Kluth JT, Jagust WJ. Relationship of striatal dopamine synthesis capacity to age and cognition. J Neurosci. 2008 Dec 24; 28(52):14320-8. PMID: 19109513; PMCID: PMC2880923.
      33. Baker S, Baseler H, Klein S, Carney T. Localizing sites of activation in primary visual cortex using visual-evoked potentials and functional magnetic resonance imaging. J Clin Neurophysiol. 2006 Oct; 23(5):404-15. PMID: 17016150.
        View in: PubMed

      A U.S. Department of Energy National Laboratory Managed by the University of California

      This site is running Profiles RNS version v2.10.1-414-g6fb82b0a.